The ROE (Return on Equity) of Kiadis Pharma NV (KDS.AS) is 248.91%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2020-12-31 | 248.91% |
| 2019-12-31 | -153.65% |
| 2018-12-31 | -67.51% |
| 2017-12-31 | -107.43% |
| 2016-12-31 | -156.70% |
| 2015-12-31 | -64.16% |
| 2014-12-31 | -292.51% |
| 2013-12-31 | -128.54% |
| 2012-12-31 | -53.32% |